Patents Assigned to Newport Pharmaceuticals International
  • Patent number: 4529543
    Abstract: A polypeptide-like material is prepared from liver cells and is named hepatosin. Hepatosin acts as an immune modulator or immunorestorative agent.
    Type: Grant
    Filed: June 8, 1984
    Date of Patent: July 16, 1985
    Assignee: Newport Pharmaceuticals International
    Inventors: Gerhard E. Renoux, Micheline J. Renoux
  • Patent number: 4512981
    Abstract: Inosiplex has been found to be useful as an anti-inflammatory agent, e.g., to treat rheumatoid arthritis. There is no need to employ known anti-inflammatory agents, e.g., indomethacin or aspirin, with it and, in fact, the anti-inflammatory action of inosiplex is reduced if either of these two drugs are present.
    Type: Grant
    Filed: December 20, 1982
    Date of Patent: April 23, 1985
    Assignee: Newport Pharmaceuticals International, Inc.
    Inventor: Paul Gordon
  • Patent number: 4510144
    Abstract: There are prepared compounds of the formulae ##STR1## Where R.sup.1 is H, lower alkyl S--, ##STR2## NH.sub.2 or halogen, R.sup.2 is OH, lower alkyl S--, halogen, NH.sub.2 or SH,R is OH, SH, lower alkyl S--, or halogen andR.sup.3 is OH, SH, lower alkyl S--, halogen or NH.sub.2.The compounds have antiviral and immuno-modulating activity.
    Type: Grant
    Filed: September 30, 1982
    Date of Patent: April 9, 1985
    Assignee: Newport Pharmaceuticals International
    Inventors: John W. Hadden, Lionel N. Simon, Alfredo Giner-Sorolla
  • Patent number: 4457919
    Abstract: There are prepared compounds of the formula ##STR1## where R.sup.1 is alkyl of 1 to 8 carbon atoms and R.sup.2 is the ester group of an unsubstituted monocarboxylic acid, aromatic carboxylic acid, aminocarboxylic acid, unsubstituted dicarboxylic acid, phosphoric acid, or nitric acid or a glycoside or an acetaldehyde acetal. The compounds are immunomodulators, have antiviral activity and antitumor activity and also are enzyme inhibitors. The compounds can also be used to introduce the corresponding alcohol into biological systems, in some cases with enhanced potency.
    Type: Grant
    Filed: May 17, 1982
    Date of Patent: July 3, 1984
    Assignees: Newport Pharmaceutical International, Inc., Sloan-Kettering Institute
    Inventors: Lionel N. Simon, Alfredo Giner-Sorolla, Alvin Guttag
  • Patent number: 4451478
    Abstract: There are prepared compounds of the formulae ##STR1## where R is lower alkyl, chlorine, or bromine and n is an integer from 1 to 5. The compounds of formula (1) can be used to make erythro-9-(2-hydroxy-3-nonyl) hypoxanthine and its homologues and also to make the compounds of formulae (2) and (3). All three classes of compounds are useful as immunomodulators.
    Type: Grant
    Filed: March 12, 1982
    Date of Patent: May 29, 1984
    Assignee: Newport Pharmaceuticals International, Inc.
    Inventors: Lionel N. Simon, Hans-Rudolf Mueller, Hans Zutter
  • Patent number: 4387226
    Abstract: There are prepared compound of the formulae ##STR1## Where R.sup.1 is H, lower alkyl S--, lower alkyl ##STR2## NH.sub.2 or halogen, R.sup.2 is OH, lower alkyl S--, halogen, NH.sub.2 or SHR is OH, SH, lower alkyl S--, or halogen andR.sup.3 is OH, SH, lower alkyl S--, halogen or NH.sub.2.The compounds have antiviral and immunomodulating activity.
    Type: Grant
    Filed: August 26, 1981
    Date of Patent: June 7, 1983
    Assignees: Newport Pharmaceuticals International, Inc., Sloan-Kettering Institute For Cancer Research
    Inventors: John W. Hadden, Lionel N. Simon, Alfredo Giner-Sorolla
  • Patent number: 4340726
    Abstract: There are prepared compounds of the formula ##STR1## where R.sup.1 is alkyl of 1 to 8 carbon atoms and R.sup.2 is the ester group of an unsubstituted monocarboxylic acid, aromatic carboxylic acid, aminocarboxylic acid, unsubstituted dicarboxylic acid, phosphoric acid, or nitric acid or a glycoside or an acetaldehyde acetal. The compounds are immunomodulators, have antiviral activity and antitumor activity and also are enzyme inhibitors. The compounds can also be used to introduce the corresponding alcohol into biological systems, in some cases with enhanced potency.
    Type: Grant
    Filed: March 14, 1980
    Date of Patent: July 20, 1982
    Assignees: Newport Pharmaceuticals International, Inc., Sloan-Kettering Institute for Cancer Research
    Inventors: Lionel N. Simon, Alfredo Giner-Sorolla, Alvin Guttag
  • Patent number: 4221794
    Abstract: Compounds of the formula ##STR1## where X is OH, NH.sub.2, SH, OR or SR (where R is alkyl of 1 to 4 carbon atoms or benzyl), R.sup.1 is H or alkyl of 1 to 8 carbon atoms, R.sup.2 is H or methyl, Y is the salt of an amine of the formula ##STR2## where R.sup.3 and R.sup.4 are lower alkyl, e.g., 1 to 4 carbon atoms and n is an integer of 2 to 4 with p-acetamidobenzoic acid and where z is a number from 0 to 10 are useful as immunomodulators, as antiviral agents and in specific cases have anti-leukemic activity. The compounds and compositions where z is 1 to 10 are novel per se. When R.sup.2 is H the presence of Y enhances the immunoregulatory activity and the antiviral activity. If X is the NH.sub.2 there is immunoinhibitory activity but no immunostimulatory (immunopotentiatory) activity.
    Type: Grant
    Filed: June 21, 1979
    Date of Patent: September 9, 1980
    Assignees: Newport Pharmaceuticals International, Inc., Sloan-Kettering Institute for Cancer Research
    Inventors: Lionel N. Simon, John W. Hadden
  • Patent number: 4221910
    Abstract: There are prepared compounds of the formula ##STR1## where X is OH, R.sup.2 is CH.sub.3 and R.sup.1 is alkyl of 1 to 8 carbon atoms. The compounds are immunopotentiators, have antiviral activity and anti-leukemic activity.
    Type: Grant
    Filed: September 15, 1978
    Date of Patent: September 9, 1980
    Assignees: Newport Pharmaceuticals International, Inc., Sloan-Kettering Institute for Cancer Research
    Inventor: Alfredo Giner-Sorolla